Home › Melanoma › California › Orange
Pag-aaral pangklinika para sa Melanoma sa Orange, CA
14 pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Orange (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Nagre-recruitPhase 3
- St. Joseph Hospital Orange, Orange
- University of California Irvine, UCI Medical Center, Orange
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Nagre-recruitPhase 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Children's Hospital of Orange County, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
- Children's Hospital of Orange County, Orange
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Nagre-recruitMaagang Phase 1
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Nagre-recruitPhase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Nagre-recruitPhase 1/2
- University of California Irvine, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Nagre-recruitPhase 3
- University of California Irvine Medical Center, Orange
A Study of VET3-TGI in Patients With Solid Tumors
Nagre-recruitPhase 1
- UC Irvine Health, Orange
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
Nagre-recruitPhase 2
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Orange
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Orange
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN33 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA26 pag-aaral
- Philadelphia, PA23 pag-aaral
- San Francisco, CA22 pag-aaral
- Columbus, OH21 pag-aaral
- St. Louis, MO21 pag-aaral
- Atlanta, GA21 pag-aaral
- Durham, NC21 pag-aaral
Iba pang pag-aaral sa Orange
- Non-Small Cell Lung Cancer25 pag-aaral
- Metastatic Cancer20 pag-aaral
- Colorectal Cancer16 pag-aaral
- Kanser sa Ovary16 pag-aaral
- Kanser sa Pancreas15 pag-aaral
- Kanser sa Atay (Hepatocellular Carcinoma)14 pag-aaral
- Kanser sa Suso14 pag-aaral
- Kanser sa Baga14 pag-aaral
- Kanser sa Prostate14 pag-aaral
- Kanser sa Tiyan13 pag-aaral
- Kanser (lahat ng uri)13 pag-aaral
- Acute Myeloid Leukemia13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.